Full-Time

Executive Director

Portfolio Management, Rare Disease

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$253k - $316.5kAnnually

+ Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

Hybrid model requires in-office presence three days per week.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in life science or related field; Advanced degree preferred.
  • Targeting 15 years of progressively responsible, relevant experience focusing on program management with 10 years in a leadership role which includes experience managing cross-functional project teams.
  • Strong understanding of the drug development process from preclinical pharmacology through to regulatory approval and the principles, concepts, practices, and standards of pharmaceutical program management.
  • Executive presence and communication skills required.
  • Excellent knowledge of project management discipline and its application to drug development required to deliver time, cost, quality and risk management to teams.
  • Advanced meeting facilitation skills and ability to lead cross-functional teams that include executive and senior management without direct authority.
  • Financial management knowledge required.
  • Rare Disease experience required.
  • Excellent interpersonal, organizational, written and verbal communication skills.
  • Independent, motivated, team leader with the ability to thrive in a matrix environment.
  • Ability to support multiple asset teams simultaneously with strong organizational and time management skills and attention to detail.
  • Ability to accommodate and lead teams through shifting priorities, demands and timelines.
  • Ability to elicit cooperation from a wide variety of sources and to be persuasive, encouraging and motivating.
  • Adept at creating and communicating a clear vision for a program among team members to facilitate alignment of resources to achieve program and corporate goals.
  • Proven track record of implementing Project Management tools, methodologies, practices and infrastructure, as related to the biopharmaceutical Industry.
  • In-depth knowledge and skill with Microsoft (MS) suite including MS PowerPoint, MS Project, MS Word, MS Excel.
Responsibilities
  • Lead Asset Strategy Teams (ASTs) for Rare Disease Franchise by driving the teams to execute on the strategic vision of the Rare Disease portfolio.
  • Drive planning for key drug development stage-gate decision points after Phase 1 and co-chair stage-gate committee for Rare Disease franchise.
  • Manages an integrated program budget and resource plan in partnership with Finance team member and functional line representatives and sub-teams.
  • Facilitate resource planning, including financial and capacity assessments for Rare Disease franchise.
  • Partner with Strategic Product Planning function to establish or update Target Product Profiles (TPPs) for the Rare Disease portfolio that are aligned with the Strategic Value Proposition for the initial development and life-cycle management of the asset.
  • Coordinate formation of the ASTs for Rare Disease Franchise programs following a Go to Phase 2 (POC) decision at Stage Gate 3 and knowledge transfer from the Early-Stage AST members or Alliance Delivery Teams (ADTs) for partnered programs.
  • Collaborate with Research and Development (R&D) Operations team to ensure development team plans and timelines align with the strategic goals for the portfolio.
  • Ensure clear translation of the Strategic Value Proposition for each asset into an integrated strategic development plan for each program.
  • Proactively communicate contract milestones, scientific and financial obligations to ASTs for partnered programs to make well-informed strategic recommendations and decisions.
  • Proactively conduct risk management, and contingency and scenario planning across disciplines, ensure transparent communication of risks and escalate to executive management with appropriate speed.
  • Lead and facilitate decision analysis with the team including development and assessment of outcome scenarios with alternative development options, robust go/no go decision criteria, probability of technical and regulatory success (PTRS), and value and investment implications.
  • Ensure a coordinated approach across portfolio managers to ensure aligned execution and consistent reporting across stakeholders (ie, financial planning and analytics, executive leadership team and board of directors).
  • Other duties as assigned.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting unmet medical needs in neuroscience, ensuring that their products address significant challenges faced by patients. Their goal is to improve the quality of life for individuals with these disorders while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia received Health Canada approval for Daybue to treat Rett Syndrome.
  • The company entered an exclusive license agreement with Saniona for SAN711.
  • Acadia's awareness campaigns enhance its brand and patient engagement.

What critics are saying

  • New CCO may lead to strategic shifts disrupting current operations.
  • Exclusive license for SAN711 poses financial risks if milestones aren't met.
  • Regulatory delays for trofinetide could impact market entry timelines.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on neurological disorders with high unmet medical needs.
  • The company has a strong R&D pipeline with four product candidates.
  • Acadia collaborates with Biovail for developing pimavanserin for multiple indications.

Help us improve and share your feedback! Did you find this helpful?